Business Context and Reporting Period
This Form 8-K Current Report was filed by Senseonics Holdings, Inc. on December 21, 2018, regarding an event that occurred on December 20, 2018. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. It reports a specific corporate event rather than periodic financial results.
Material Changes
On December 20, 2018, Senseonics Incorporated, a wholly-owned subsidiary, amended its Distribution Agreement with Roche Diagnostics International AG and Roche Diabetes Care GmbH. The amendment extends the term of the agreement, originally dated May 23, 2016, until January 31, 2019.
Guidance, Outlook, and Risks
Management indicated that the Company and Roche are continuing discussions regarding a potential longer-term extension of the Distribution Agreement beyond the current January 31, 2019, expiration. The filing notes that the full text of the Amendment will be included as an exhibit to the Company's Annual Report on Form 10-K for the year ending December 31, 2018.
Investor Verification Checklist
- Verify the terms of the full Amendment to the Distribution Agreement once filed as an exhibit to the 2018 Form 10-K.
- Monitor future announcements regarding the outcome of discussions for a longer-term extension with Roche.
- Review the upcoming 2018 Form 10-K for comprehensive financial data and risk factors not included in this 8-K.